PharmaShots | Incisive News in 3 Shots

Subscribe Now

Overexpressing

Pfizer's Trazimera (trastuzumab-biosimilar) Receives FDA's Approval for HER-2+ Breast Cancer and m-Gastric/GEJ Cancer

Pfizer's Trazimera (trastuzumab-biosimilar) Receives FDA's Approval for HER-2+ Breast Cancer and m-Gastric/GEJ Cancer

March 12, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us